Maravai LifeSciences Holdings IncNASDAQ:MRVI
- LAST PRICE8.3100
- TODAY'S CHANGE (%)-0.1200 (-1.4235%)
- Bid / Lots8.3000/ 4
- Ask / Lots8.3200/ 7
- Open / Previous Close8.4500 / 8.4300
- Day Range
- 52 Week Range
- Volume717,251
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRVI |
|---|---|---|
| 09:32 ET | 12140 | 8.35 |
| 09:34 ET | 1637 | 8.275 |
| 09:36 ET | 2200 | 8.31 |
| 09:38 ET | 2039 | 8.3241 |
| 09:39 ET | 300 | 8.36 |
| 09:41 ET | 1302 | 8.35 |
| 09:43 ET | 456 | 8.355 |
| 09:45 ET | 3083 | 8.33 |
| 09:48 ET | 2038 | 8.32 |
| 09:50 ET | 1567 | 8.325 |
| 09:52 ET | 700 | 8.3125 |
| 09:54 ET | 1415 | 8.305 |
| 09:56 ET | 100 | 8.305 |
| 09:57 ET | 1818 | 8.3 |
| 09:59 ET | 2502 | 8.29 |
| 10:01 ET | 611 | 8.32 |
| 10:03 ET | 14094 | 8.32 |
| 10:06 ET | 3144 | 8.325 |
| 10:08 ET | 5670 | 8.35 |
| 10:10 ET | 4200 | 8.35 |
| 10:12 ET | 2798 | 8.35 |
| 10:14 ET | 6773 | 8.36 |
| 10:15 ET | 4900 | 8.355 |
| 10:17 ET | 2866 | 8.325 |
| 10:19 ET | 2300 | 8.325 |
| 10:21 ET | 4845 | 8.325 |
| 10:24 ET | 558 | 8.325 |
| 10:26 ET | 4498 | 8.335 |
| 10:28 ET | 1411 | 8.345 |
| 10:30 ET | 4974 | 8.345 |
| 10:32 ET | 13081 | 8.365 |
| 10:33 ET | 7591 | 8.39 |
| 10:35 ET | 200 | 8.385 |
| 10:37 ET | 1363 | 8.375 |
| 10:39 ET | 602 | 8.375 |
| 10:42 ET | 1932 | 8.38 |
| 10:44 ET | 3736 | 8.365 |
| 10:46 ET | 700 | 8.365 |
| 10:48 ET | 2000 | 8.365 |
| 10:50 ET | 18467 | 8.36 |
| 10:51 ET | 1209 | 8.365 |
| 10:53 ET | 27889 | 8.345 |
| 10:55 ET | 4119 | 8.35 |
| 10:57 ET | 8929 | 8.355 |
| 11:00 ET | 2938 | 8.36 |
| 11:02 ET | 1001 | 8.365 |
| 11:04 ET | 821 | 8.36 |
| 11:06 ET | 430 | 8.35 |
| 11:08 ET | 1856 | 8.36 |
| 11:09 ET | 4121 | 8.345 |
| 11:11 ET | 700 | 8.345 |
| 11:13 ET | 2528 | 8.335 |
| 11:15 ET | 3145 | 8.3175 |
| 11:18 ET | 1890 | 8.305 |
| 11:20 ET | 973 | 8.3 |
| 11:22 ET | 300 | 8.305 |
| 11:24 ET | 4275 | 8.315 |
| 11:26 ET | 1617 | 8.315 |
| 11:27 ET | 12309 | 8.325 |
| 11:29 ET | 818 | 8.325 |
| 11:31 ET | 2639 | 8.32 |
| 11:33 ET | 800 | 8.31 |
| 11:36 ET | 8696 | 8.275 |
| 11:38 ET | 3479 | 8.28 |
| 11:40 ET | 1874 | 8.275 |
| 11:42 ET | 5294 | 8.265 |
| 11:44 ET | 2578 | 8.28 |
| 11:45 ET | 607 | 8.285 |
| 11:47 ET | 100 | 8.29 |
| 11:49 ET | 106377 | 8.27 |
| 11:51 ET | 8666 | 8.31 |
| 11:54 ET | 100 | 8.315 |
| 11:56 ET | 6306 | 8.305 |
| 11:58 ET | 13851 | 8.275 |
| 12:00 ET | 1200 | 8.27 |
| 12:02 ET | 103755 | 8.27 |
| 12:03 ET | 7966 | 8.245 |
| 12:05 ET | 670 | 8.24 |
| 12:07 ET | 300 | 8.245 |
| 12:09 ET | 14236 | 8.255 |
| 12:12 ET | 7234 | 8.29 |
| 12:14 ET | 17970 | 8.29 |
| 12:16 ET | 2015 | 8.29 |
| 12:18 ET | 100 | 8.295 |
| 12:20 ET | 4887 | 8.295 |
| 12:21 ET | 1750 | 8.295 |
| 12:23 ET | 55809 | 8.31 |
May 29, 2024
DJ Maravai LifeSciences Shares Fall 16% After Stock-Sale Proposals, from 1:13PM ET on Wednesday May 29, 2024 by Dow Jones
1:13PM ET on Wednesday May 29, 2024 by Dow Jones
May 13, 2024
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center, from 8:00AM ET on Monday May 13, 2024 by Dow Jones
8:00AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Maravai LifeSciences Holdings Inc | 2.2B | -8.4x | --- |
Zai Lab Ltd | 1.9B | -5.7x | --- |
ADMA Biologics Inc | 2.4B | -511.0x | --- |
Galapagos NV | 1.8B | 52.2x | --- |
Vericel Corp | 2.2B | 4,503.1x | --- |
TG Therapeutics Inc | 2.4B | 72.0x | --- |
Company Information
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.
Contact Information
- Headquarters
- 10770 Wateridge Circle Suite 200 Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-546-0004
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Carl Hull
- Chief Executive Officer
- William Martin
- Chief Financial Officer
- Kevin Herde
- President - Nucleic Acid Production
- Andrew Burch
- Executive Vice President, Chief Commercial Officer
- Rebecca Buzzeo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $274.1M |
Shares Outstanding | 251.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.06 |
EPS | $-0.99 |
Book Value | $1.66 |
P/E Ratio | -8.4x |
Price/Sales (TTM) | 7.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -19.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
